driven by the PitchBook Platform
Provider of a platform technology for disease-specific target identification. The company develops antibodies that mimic the specificity of T-cell receptors in the immune system.
You’re viewing a free company profile from the PitchBook Platform. To explore pureMHC’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.